Antiviral Activity of Approved Anti-Inflammatory Drugs and Prospects for Drug Repurposing: A review

References (61)

1. 1 Ethanolic Extract of Propolis (EEP) Enhances the Apoptosis- Inducing Potential of TRAIL in Cancer Cells [DOI]
2. 2 Drug repurposing approach to fight COVID-19 [DOI]
3. 3 Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies [DOI]
4. 4 The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells [DOI]
5. 5 Antiviral drug discovery: preparing for the next pandemic [DOI]
6. 6 Indomethacin Has a Potent Antiviral Activity against Sars Coronavirus [DOI]
7. 7 Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-?B-inhibiting activity [DOI]
8. 8 Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection [DOI]
9. 9 A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery [DOI]
10. 10 Structure-Based Discovery of the Novel Antiviral Properties of Naproxen against the Nucleoprotein of Influenza A Virus [DOI]
11. 11 Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation In Vitro [DOI]
12. 12 Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus [DOI]
13. 13 Antiviral activity of aspirin against RNA viruses of the respiratory tract—an in vitro study [DOI]
14. 14 Repurposing old drugs as antiviral agents for coronaviruses [DOI]
15. 15 Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export [DOI]
16. 16 Aspirin Attenuates Cytomegalovirus Infectivity and Gene Expression Mediated by Cyclooxygenase-2 in Coronary Artery Smooth Muscle Cells [DOI]
17. 17 NOVEL MECHANISM OF INHIBITION OF CYTOMEGALOVIRUS BY THE EXPERIMENTAL IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1,2 [DOI]
18. 18 Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection [DOI]
19. 19 Budesonide and Formoterol Reduce Early Innate Anti-Viral Immune Responses In Vitro [DOI]
20. 20 Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways [DOI]
21. 21 Effect of dexamethasone on respiratory syncytial virus‐induced lung inflammation in children: results of a randomized, placebo controlled clinical trial [DOI]
22. 22 Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity [DOI]
23. 23 The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses [DOI]
24. 24 Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation [DOI]
25. 25 Roflumilast Inhibits Respiratory Syncytial Virus Infection in Human Differentiated Bronchial Epithelial Cells [DOI]
26. 26 Aspirin inhibits hepatitis C virus entry by downregulating claudin‐1 [DOI]
27. 27 A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection [DOI]
28. 28 Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) [DOI]
29. 29 Molecular beacons to identify gifted microbes for genome mining [DOI]
30. 30 In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2 [DOI]
31. 31 Molecular dissection of an inhibitor targeting the HIV integrase dependent preintegration complex nuclear import [DOI]
32. 32 In silico analysis and experimental validation of azelastine hydrochloride (N4) targeting sodium taurocholate co‐transporting polypeptide ( NTCP ) in HBV therapy [DOI]
33. 33 Salicylates Inhibit Flavivirus Replication Independently of Blocking Nuclear Factor Kappa B Activation [DOI]
34. 34 Levocetirizine inhibits rhinovirus-induced ICAM-1 and cytokine expression and viral replication in airway epithelial cells [DOI]
35. 35 Downregulation of inducible nitric oxide synthase (iNOS) expression is implicated in the antiviral activity of acetylsalicylic acid in HCV-expressing cells [DOI]
36. 36 Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases [DOI]
37. 37 Selective Inhibition of Hepatitis C Virus Infection by Hydroxyzine and Benztropine [DOI]
38. 38 Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity [DOI]
39. 39 Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling [DOI]
40. 40 Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells [DOI]
41. 41 Leflunomide: a possible alternative for gangciclovir sensitive and resistant cytomegalovirus infections [DOI]
42. 42 Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings [DOI]
43. 43 Possible antiviral activity of montelukast against Herpes Simplex Virus type-1 and Human Adeno Virus in vitro [DOI]
44. 44 A comprehensive procedure for antiviral inhibitor discovery using EV71 as an example [DOI]
45. 45 Anti-Human Rhinovirus 1B Activity of Dexamethasone viaGCR-Dependent Autophagy Activation [DOI]
46. 46 Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine.
47. 47 Treatment of HTLV-III/LAV-infected patients with D-penicillamine.
48. 48 Prolonged antiviral activity of D-penicillamine in human immunodeficiency virus-infected homosexual men [DOI]
49. 49 Effect of d -Penicillamine on Poliovirus Replication In HeLa Cells [DOI]
50. 50 Discovering Drugs for the Treatment of Ebola Virus [DOI]
51. 51 Drug repositioning: Progress and challenges in drug discovery for various diseases [DOI]
52. 52 Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions [DOI]
53. 53 Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus [DOI]
54. 54 Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary [DOI]
55. 55 Drug repurposing for the treatment of COVID-19 [DOI]
56. 56 Repurposing Drugs: An Empowering Approach to Drug Discovery and Development [DOI]
57. 57 Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19 [DOI]
58. 58 The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue [DOI]
59. 59 Piroxicam inhibits herpes simplex virus type 1 infection in vitro [DOI]
60. 60 Comprehensive review on repurposing of approved medicine in the management of COVID-19 infection [DOI]
61. 61 Onaylanmış Merkezi Etkili İlaçların Antiviral Aktivitesi: Bir Anlatı İncelemesi [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Antimicrobial Profile of Selected Snake Venoms and Their Associated Enzymatic Activities — shares topic coverage
• In vitro Antiviral Activity of Nauclea latifolia Root Bark Extract Against the Respiratory Syncytial Virus — shares topic coverage
• Synthesis, Antiviral and Kinesin Eg5 Activities of New Indomethacin Analogues — shares topic coverage
• Review on Ethno-botany, Virucidal Activity, Phytochemistry and Toxicology of Solanum genus: Potential Bio-resources for the Therapeutic Management of Covid-19 — shares topic coverage
• Aloe vera (L.) Burm. F. as a Potential Anti-COVID-19 Plant: A Mini-review of Its Antiviral Activity — shares topic coverage